Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen

R. C. Dickson, J. E. Everhart, J. R. Lake, Y. Wei, E. C. Seaberg, R. H. Wiesner, R. K. Zetterman, T. L. Pruett, M. B. Ishitani, J. H. Hoofnagle, K. M. Detre, A. J. Demetris, S. Belle, Y. Wei, M. Lombardero, E. Seaberg, S. Lawlor, H. Eng, S. Fitzgerald, J. HaberG. L. Swanson, R. Wiesner, R. Krom, M. K. Porayko, L. Schwerman, C. Groettum, R. K. Zetterman, Jr Shaw B., K. Taylor, N. Ascher, J. Lake, C. Bremer-Kamp, J. Everhart, S. Shores

Research output: Contribution to journalArticle

363 Citations (Scopus)

Abstract

Background and Aims: Organ donors are a potential source of transmissible disease after transplantation. The aim of this study was to evaluate the risk of acquiring hepatitis B among transplantation recipients of livers from donors without serum hepatitis B surface antigen (HBsAg) but with antibody to hepatitis B core antigen (anti-HBc). Methods: The transplantation experience of four centers between 1989 and 1994 was reviewed. Recipients of livers from 674 donors were considered informative for hepatitis B virus transmission. Results: Hepatitis B developed in 18 of 23 recipients of livers from anti-HBc-positive donors (78%) compared with only 3 of 651 recipients of anti-HBc-negative donor livers (0.5%) (P < 0.0001). HBsAg persisted in all recipients with donor-related hepatitis B. Liver histology showed chronic hepatitis of moderate severity in 2 of 13 recipients at 1 year and 5 of 8 recipients between 1.6 and 4.5 years from transplantation. Liver transplantation from an anti-HBc-positive donor was associated with decreased 4-year survival (adjusted mortality hazard ratio of 2.4; 95% confidence interval, 1.44.0). Conclusions: De novo posttransplantation hepatitis B infection occurs at a high rate in recipients of donors with anti-HBc. Transmission of hepatitis B through transplantation suggests that the virus may persist in the liver despite serological resolution of infection.

Original languageEnglish (US)
Pages (from-to)1668-1674
Number of pages7
JournalGastroenterology
Volume113
Issue number5
DOIs
StatePublished - Jan 1 1997

Fingerprint

Hepatitis B Core Antigens
Hepatitis B
Liver Transplantation
Tissue Donors
Antibodies
Transplantation
Liver
Hepatitis B Surface Antigens
Chronic Hepatitis
Infection
Hepatitis B virus
Histology
Confidence Intervals
Viruses
Survival
Mortality

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Dickson, R. C., Everhart, J. E., Lake, J. R., Wei, Y., Seaberg, E. C., Wiesner, R. H., ... Shores, S. (1997). Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology, 113(5), 1668-1674. https://doi.org/10.1053/gast.1997.v113.pm9352871

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. / Dickson, R. C.; Everhart, J. E.; Lake, J. R.; Wei, Y.; Seaberg, E. C.; Wiesner, R. H.; Zetterman, R. K.; Pruett, T. L.; Ishitani, M. B.; Hoofnagle, J. H.; Detre, K. M.; Demetris, A. J.; Belle, S.; Wei, Y.; Lombardero, M.; Seaberg, E.; Lawlor, S.; Eng, H.; Fitzgerald, S.; Haber, J.; Swanson, G. L.; Wiesner, R.; Krom, R.; Porayko, M. K.; Schwerman, L.; Groettum, C.; Zetterman, R. K.; Shaw B., Jr; Taylor, K.; Ascher, N.; Lake, J.; Bremer-Kamp, C.; Everhart, J.; Shores, S.

In: Gastroenterology, Vol. 113, No. 5, 01.01.1997, p. 1668-1674.

Research output: Contribution to journalArticle

Dickson, RC, Everhart, JE, Lake, JR, Wei, Y, Seaberg, EC, Wiesner, RH, Zetterman, RK, Pruett, TL, Ishitani, MB, Hoofnagle, JH, Detre, KM, Demetris, AJ, Belle, S, Wei, Y, Lombardero, M, Seaberg, E, Lawlor, S, Eng, H, Fitzgerald, S, Haber, J, Swanson, GL, Wiesner, R, Krom, R, Porayko, MK, Schwerman, L, Groettum, C, Zetterman, RK, Shaw B., J, Taylor, K, Ascher, N, Lake, J, Bremer-Kamp, C, Everhart, J & Shores, S 1997, 'Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen', Gastroenterology, vol. 113, no. 5, pp. 1668-1674. https://doi.org/10.1053/gast.1997.v113.pm9352871
Dickson, R. C. ; Everhart, J. E. ; Lake, J. R. ; Wei, Y. ; Seaberg, E. C. ; Wiesner, R. H. ; Zetterman, R. K. ; Pruett, T. L. ; Ishitani, M. B. ; Hoofnagle, J. H. ; Detre, K. M. ; Demetris, A. J. ; Belle, S. ; Wei, Y. ; Lombardero, M. ; Seaberg, E. ; Lawlor, S. ; Eng, H. ; Fitzgerald, S. ; Haber, J. ; Swanson, G. L. ; Wiesner, R. ; Krom, R. ; Porayko, M. K. ; Schwerman, L. ; Groettum, C. ; Zetterman, R. K. ; Shaw B., Jr ; Taylor, K. ; Ascher, N. ; Lake, J. ; Bremer-Kamp, C. ; Everhart, J. ; Shores, S. / Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. In: Gastroenterology. 1997 ; Vol. 113, No. 5. pp. 1668-1674.
@article{8576cdcefc5e40e4a83cd5dd20854af7,
title = "Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen",
abstract = "Background and Aims: Organ donors are a potential source of transmissible disease after transplantation. The aim of this study was to evaluate the risk of acquiring hepatitis B among transplantation recipients of livers from donors without serum hepatitis B surface antigen (HBsAg) but with antibody to hepatitis B core antigen (anti-HBc). Methods: The transplantation experience of four centers between 1989 and 1994 was reviewed. Recipients of livers from 674 donors were considered informative for hepatitis B virus transmission. Results: Hepatitis B developed in 18 of 23 recipients of livers from anti-HBc-positive donors (78{\%}) compared with only 3 of 651 recipients of anti-HBc-negative donor livers (0.5{\%}) (P < 0.0001). HBsAg persisted in all recipients with donor-related hepatitis B. Liver histology showed chronic hepatitis of moderate severity in 2 of 13 recipients at 1 year and 5 of 8 recipients between 1.6 and 4.5 years from transplantation. Liver transplantation from an anti-HBc-positive donor was associated with decreased 4-year survival (adjusted mortality hazard ratio of 2.4; 95{\%} confidence interval, 1.44.0). Conclusions: De novo posttransplantation hepatitis B infection occurs at a high rate in recipients of donors with anti-HBc. Transmission of hepatitis B through transplantation suggests that the virus may persist in the liver despite serological resolution of infection.",
author = "Dickson, {R. C.} and Everhart, {J. E.} and Lake, {J. R.} and Y. Wei and Seaberg, {E. C.} and Wiesner, {R. H.} and Zetterman, {R. K.} and Pruett, {T. L.} and Ishitani, {M. B.} and Hoofnagle, {J. H.} and Detre, {K. M.} and Demetris, {A. J.} and S. Belle and Y. Wei and M. Lombardero and E. Seaberg and S. Lawlor and H. Eng and S. Fitzgerald and J. Haber and Swanson, {G. L.} and R. Wiesner and R. Krom and Porayko, {M. K.} and L. Schwerman and C. Groettum and Zetterman, {R. K.} and {Shaw B.}, Jr and K. Taylor and N. Ascher and J. Lake and C. Bremer-Kamp and J. Everhart and S. Shores",
year = "1997",
month = "1",
day = "1",
doi = "10.1053/gast.1997.v113.pm9352871",
language = "English (US)",
volume = "113",
pages = "1668--1674",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen

AU - Dickson, R. C.

AU - Everhart, J. E.

AU - Lake, J. R.

AU - Wei, Y.

AU - Seaberg, E. C.

AU - Wiesner, R. H.

AU - Zetterman, R. K.

AU - Pruett, T. L.

AU - Ishitani, M. B.

AU - Hoofnagle, J. H.

AU - Detre, K. M.

AU - Demetris, A. J.

AU - Belle, S.

AU - Wei, Y.

AU - Lombardero, M.

AU - Seaberg, E.

AU - Lawlor, S.

AU - Eng, H.

AU - Fitzgerald, S.

AU - Haber, J.

AU - Swanson, G. L.

AU - Wiesner, R.

AU - Krom, R.

AU - Porayko, M. K.

AU - Schwerman, L.

AU - Groettum, C.

AU - Zetterman, R. K.

AU - Shaw B., Jr

AU - Taylor, K.

AU - Ascher, N.

AU - Lake, J.

AU - Bremer-Kamp, C.

AU - Everhart, J.

AU - Shores, S.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Background and Aims: Organ donors are a potential source of transmissible disease after transplantation. The aim of this study was to evaluate the risk of acquiring hepatitis B among transplantation recipients of livers from donors without serum hepatitis B surface antigen (HBsAg) but with antibody to hepatitis B core antigen (anti-HBc). Methods: The transplantation experience of four centers between 1989 and 1994 was reviewed. Recipients of livers from 674 donors were considered informative for hepatitis B virus transmission. Results: Hepatitis B developed in 18 of 23 recipients of livers from anti-HBc-positive donors (78%) compared with only 3 of 651 recipients of anti-HBc-negative donor livers (0.5%) (P < 0.0001). HBsAg persisted in all recipients with donor-related hepatitis B. Liver histology showed chronic hepatitis of moderate severity in 2 of 13 recipients at 1 year and 5 of 8 recipients between 1.6 and 4.5 years from transplantation. Liver transplantation from an anti-HBc-positive donor was associated with decreased 4-year survival (adjusted mortality hazard ratio of 2.4; 95% confidence interval, 1.44.0). Conclusions: De novo posttransplantation hepatitis B infection occurs at a high rate in recipients of donors with anti-HBc. Transmission of hepatitis B through transplantation suggests that the virus may persist in the liver despite serological resolution of infection.

AB - Background and Aims: Organ donors are a potential source of transmissible disease after transplantation. The aim of this study was to evaluate the risk of acquiring hepatitis B among transplantation recipients of livers from donors without serum hepatitis B surface antigen (HBsAg) but with antibody to hepatitis B core antigen (anti-HBc). Methods: The transplantation experience of four centers between 1989 and 1994 was reviewed. Recipients of livers from 674 donors were considered informative for hepatitis B virus transmission. Results: Hepatitis B developed in 18 of 23 recipients of livers from anti-HBc-positive donors (78%) compared with only 3 of 651 recipients of anti-HBc-negative donor livers (0.5%) (P < 0.0001). HBsAg persisted in all recipients with donor-related hepatitis B. Liver histology showed chronic hepatitis of moderate severity in 2 of 13 recipients at 1 year and 5 of 8 recipients between 1.6 and 4.5 years from transplantation. Liver transplantation from an anti-HBc-positive donor was associated with decreased 4-year survival (adjusted mortality hazard ratio of 2.4; 95% confidence interval, 1.44.0). Conclusions: De novo posttransplantation hepatitis B infection occurs at a high rate in recipients of donors with anti-HBc. Transmission of hepatitis B through transplantation suggests that the virus may persist in the liver despite serological resolution of infection.

UR - http://www.scopus.com/inward/record.url?scp=0030830282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030830282&partnerID=8YFLogxK

U2 - 10.1053/gast.1997.v113.pm9352871

DO - 10.1053/gast.1997.v113.pm9352871

M3 - Article

C2 - 9352871

AN - SCOPUS:0030830282

VL - 113

SP - 1668

EP - 1674

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5

ER -